56872-65-2

Upstream product

• 110-91-8 morpholine 
• 56872-64-1 4-(3'-nitro-4'-fluorophenyl)-4-oxo-butanoic acid 
• 84314-04-5 4-(4-chloro-3-nitrophenyl)-4-oxobutanoic acid 

Downstream Products

• 68415-20-3 6-(4-morpholin-4-yl-3-nitro-phenyl)-4,5-dihydro-2H-pyridazin-3-one 
• 65854-68-4 3-(3-amino-4-morpholino-benzoyl)propionic acid 
• 65854-44-6 6-[3-(2-hydroxy-3-isopropylamino-propoxy)-4-morpholin-4-yl-phenyl]-4,5-dihydro-2H-pyridazin-3-one 
• 102625-20-7 2-Morpholin-4-yl-5-(5-oxo-tetrahydro-furan-3-carbonyl)-benzonitrile 
• 84313-97-3 6-(3-acetamido-4-morpholinophenyl)-4,5-dihydro-2H-pyridazine-3-one 
• 84314-02-3 3-(3-cyano-4-morpholino-benzoyl)-propionic acid 
• 103604-63-3 5-(4-Ethyl-6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-2-morpholin-4-yl-benzonitrile 
• 84314-03-4 2-(morpholin-4-yl)-5-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzonitrile 
• 84313-90-6 6-(3-amino-4-morpholino-phenyl)-4,5-dihydro-3(2H)-pyridazinone 

Relevant academic research and scientific papers

6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics

A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described.The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriov

6-(3-SUBSTITUTED AMINO-2-HYDROXYPROPOXYARYL)-4,5-DIHYDRO-3(2H)-PYRIDAZINONES

The compounds are 6-(3-substituted amino-2-hydroxypropoxyaryl)-4,5-dihydro-3(2H)-pyridazinones which are β-adrenergic blocking agents.